{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:26:57Z","timestamp":1787934417082,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11712-1","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:51:11Z","timestamp":1787932271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer"],"prefix":"10.1007","author":[{"given":"Chunhong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"3","key":"11712_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"Cancer J Clin"},{"issue":"4","key":"11712_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V et al (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31(4):1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"issue":"3","key":"11712_CR3","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/md.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU (2024) Breast cancer: a review of risk factors and diagnosis. Medicine 103(3):e36905. https:\/\/doi.org\/10.1097\/md.0000000000036905","journal-title":"Medicine"},{"key":"11712_CR4","doi-asserted-by":"publisher","unstructured":"Xu H, Xu B (2023) Breast cancer: epidemiology, risk factors and screening. Chinese journal of cancer research\u2009=\u2009Chung-kuo yen cheng yen chiu. 35(6):565\u2013583. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.06.02","DOI":"10.21147\/j.issn.1000-9604.2023.06.02"},{"issue":"12","key":"11712_CR5","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.2105\/ajph.2025.308247","volume":"115","author":"AJ White","year":"2025","unstructured":"White AJ, Hart JE, Quraishi SM et al (2025) Air pollutants and breast cancer risk: a parallel analysis of five large US prospective cohorts. Am J Public Health 115(12):2030\u20132043. https:\/\/doi.org\/10.2105\/ajph.2025.308247","journal-title":"Am J Public Health"},{"issue":"11","key":"11712_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/envhealth.5c00111","volume":"3","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhao Y, Tu H et al (2025) MeP induces metabolic disorder and liver damage at human-relevant exposure levels: role of the gut microbiota. Environ health (Washington DC) 3(11):1393\u20131405. https:\/\/doi.org\/10.1021\/envhealth.5c00111","journal-title":"Environ health (Washington DC)"},{"key":"11712_CR7","doi-asserted-by":"publisher","first-page":"115453","DOI":"10.1016\/j.ecoenv.2023.115453","volume":"264","author":"X Shen","year":"2023","unstructured":"Shen X, Zhan M, Wang Y et al (2023) Exposure to parabens and semen quality in reproductive-aged men. Ecotoxicol Environ Saf 264:115453. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.115453","journal-title":"Ecotoxicol Environ Saf"},{"key":"11712_CR8","doi-asserted-by":"publisher","first-page":"113545","DOI":"10.1016\/j.fct.2022.113545","volume":"171","author":"C Hu","year":"2023","unstructured":"Hu C, Bai Y, Li J et al (2023) Endocrine disruption and reproductive impairment of methylparaben in adult zebrafish. Food Chem toxicology: Int J published Br Industrial Biol Res Association 171:113545. https:\/\/doi.org\/10.1016\/j.fct.2022.113545","journal-title":"Food Chem toxicology: Int J published Br Industrial Biol Res Association"},{"key":"11712_CR9","doi-asserted-by":"publisher","first-page":"117311","DOI":"10.1016\/j.ecoenv.2024.117311","volume":"287","author":"H Song","year":"2024","unstructured":"Song H, Zhou H, Yang S et al (2024) Combining mendelian randomization analysis and network toxicology strategy to identify causality and underlying mechanisms of environmental pollutants with glioblastoma: a study of Methyl-4-hydroxybenzoate. Ecotoxicol Environ Saf 287:117311. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117311","journal-title":"Ecotoxicol Environ Saf"},{"key":"11712_CR10","doi-asserted-by":"publisher","first-page":"102953","DOI":"10.1016\/j.canep.2025.102953","volume":"99","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang Y, Sun Y (2025) Combining Mendelian randomization and network toxicology to decipher the causal role and molecular mechanisms of environmental pollutants in breast cancer: a focus on Methyl-4-hydroxybenzoate. Cancer Epidemiol 99:102953. https:\/\/doi.org\/10.1016\/j.canep.2025.102953","journal-title":"Cancer Epidemiol"},{"key":"11712_CR11","doi-asserted-by":"publisher","unstructured":"Balwierz R, Biernat P, Jasi\u0144ska-Balwierz A et al (2023) Potential carcinogens in makeup cosmetics. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph20064780","DOI":"10.3390\/ijerph20064780"},{"issue":"8","key":"11712_CR12","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C et al (2016) TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44(8):e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"11712_CR13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y et al (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118","journal-title":"Genome Res"},{"issue":"10031","key":"11712_CR14","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/s0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, Hoffman-Censits J, Powles T et al (2016) Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet (London England) 387(10031):1909\u20131920. https:\/\/doi.org\/10.1016\/s0140-6736(16)00561-4","journal-title":"Lancet (London England)"},{"issue":"7693","key":"11712_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"issue":"3","key":"11712_CR16","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S et al (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Cambridge (Mass)) 2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"Innov (Cambridge (Mass))"},{"issue":"22\u201323","key":"11712_CR17","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu X, Meng J, Zhou Y et al (2021) MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics (Oxford England) 36(22\u201323):5539\u20135541. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018","journal-title":"Bioinformatics (Oxford England)"},{"issue":"8","key":"11712_CR18","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/jci91095","volume":"127","author":"J Jeschke","year":"2017","unstructured":"Jeschke J, Bizet M, Desmedt C et al (2017) DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J Clin Investig 127(8):3090\u20133102. https:\/\/doi.org\/10.1172\/jci91095","journal-title":"J Clin Investig"},{"issue":"12","key":"11712_CR19","doi-asserted-by":"publisher","first-page":"i197","DOI":"10.1093\/bioinformatics\/btv268","volume":"31","author":"F Petralia","year":"2015","unstructured":"Petralia F, Wang P, Yang J et al (2015) Integrative random forest for gene regulatory network inference. Bioinformatics (Oxford England) 31(12):i197\u2013205. https:\/\/doi.org\/10.1093\/bioinformatics\/btv268","journal-title":"Bioinformatics (Oxford England)"},{"key":"11712_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ins.2013.07.007","volume":"250","author":"V L\u00f3pez","year":"2013","unstructured":"L\u00f3pez V, Fern\u00e1ndez A, Garc\u00eda S et al (2013) An insight into classification with imbalanced data: empirical results and current trends on using data intrinsic characteristics. Inf Sci 250:113\u2013141. https:\/\/doi.org\/10.1016\/j.ins.2013.07.007","journal-title":"Inf Sci"},{"key":"11712_CR21","doi-asserted-by":"publisher","unstructured":"Zhang J, Li H, Tao W et al (2025) GseaVis: an R package for enhanced visualization of gene set enrichment analysis in biomedicine. Med Res https:\/\/doi.org\/10.1002\/mdr2.70000","DOI":"10.1002\/mdr2.70000"},{"key":"11712_CR22","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R et al (2021) IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol 12:687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975","journal-title":"Front Immunol"},{"issue":"1","key":"11712_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019","journal-title":"Cell Rep"},{"issue":"10","key":"11712_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"issue":"4","key":"11712_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V et al (2017) Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171(4):934\u2013949e916. https:\/\/doi.org\/10.1016\/j.cell.2017.09.028","journal-title":"Cell"},{"key":"11712_CR26","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260","DOI":"10.1093\/bib\/bbab260"},{"issue":"14","key":"11712_CR27","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.Can-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H et al (2012) CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 72(14):3499\u20133511. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-1370","journal-title":"Cancer Res"},{"issue":"21","key":"11712_CR28","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX et al (2018) GSCALite: a web server for gene set cancer analysis. Bioinformatics (Oxford England) 34(21):3771\u20133772. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411","journal-title":"Bioinformatics (Oxford England)"},{"issue":"11","key":"11712_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41568-025-00854-3","volume":"25","author":"M Parrish","year":"2025","unstructured":"Parrish M, Kuperwasser C (2025) Environmental endocrine disruptors: rethinking the origins of early-onset ER(+) breast cancer. Nat Rev Cancer 25(11):819\u2013820. https:\/\/doi.org\/10.1038\/s41568-025-00854-3","journal-title":"Nat Rev Cancer"},{"key":"11712_CR30","doi-asserted-by":"publisher","first-page":"1573526","DOI":"10.3389\/fendo.2025.1573526","volume":"16","author":"X Han","year":"2025","unstructured":"Han X, Jin X (2025) The impact, mechanisms and prevention strategies of environmental endocrine disruptors on male reproductive health. Front Endocrinol (Lausanne) 16:1573526. https:\/\/doi.org\/10.3389\/fendo.2025.1573526","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11712_CR31","doi-asserted-by":"publisher","first-page":"126349","DOI":"10.1016\/j.envpol.2025.126349","volume":"375","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zhang Y, She J et al (2025) Novel insights into the causal relationship between endocrine-disrupting chemicals and breast cancer mediated by circulating metabolites. Environ pollut Barking Essex: 1987) 375:126349. https:\/\/doi.org\/10.1016\/j.envpol.2025.126349","journal-title":"Environ pollution (Barking Essex: 1987)"},{"issue":"1","key":"11712_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13058-026-02225-8","volume":"28","author":"Y Fang","year":"2026","unstructured":"Fang Y, Guo C, Zheng F et al (2026) HSP90AA1-VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K\/AKT signaling. Breast Cancer Res BCR 28(1):45. https:\/\/doi.org\/10.1186\/s13058-026-02225-8","journal-title":"Breast cancer research: BCR"},{"key":"11712_CR33","doi-asserted-by":"publisher","first-page":"639596","DOI":"10.3389\/fcell.2021.639596","volume":"9","author":"H Liu","year":"2021","unstructured":"Liu H, Zhang Z, Huang Y et al (2021) Plasma HSP90AA1 predicts the risk of breast cancer onset and distant metastasis. Front Cell Dev Biol 9:639596. https:\/\/doi.org\/10.3389\/fcell.2021.639596","journal-title":"Front Cell Dev Biol"},{"key":"11712_CR34","doi-asserted-by":"publisher","first-page":"139443","DOI":"10.1016\/j.ijbiomac.2024.139443","volume":"298","author":"O Chen","year":"2025","unstructured":"Chen O, Fu L, Wang Y et al (2025) Targeting HSP90AA1 to overcome multiple drug resistance in breast cancer using magnetic nanoparticles loaded with salicylic acid. Int J Biol Macromol 298:139443. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139443","journal-title":"Int J Biol Macromol"},{"key":"11712_CR35","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.4c05174","author":"FA Gowans","year":"2024","unstructured":"Gowans FA, Forte N, Hatcher J et al (2024) Covalent degrader of the oncogenic transcription factor \u03b2-catenin. J Am Chem Soc. https:\/\/doi.org\/10.1021\/jacs.4c05174","journal-title":"J Am Chem Soc"},{"issue":"11","key":"11712_CR36","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.ccell.2024.09.009","volume":"42","author":"R Kudo","year":"2024","unstructured":"Kudo R, Safonov A, Jones C et al (2024) Long-term breast cancer response to CDK4\/6 inhibition defined by TP53-mediated geroconversion. Cancer Cell 42(11):1919\u20131935e1919. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.009","journal-title":"Cancer Cell"},{"key":"11712_CR37","doi-asserted-by":"publisher","unstructured":"Wu SY, Xiao Y, Wei JL et al (2021) MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer 9(7). https:\/\/doi.org\/10.1136\/jitc-2021-002528","DOI":"10.1136\/jitc-2021-002528"},{"issue":"50","key":"11712_CR38","doi-asserted-by":"publisher","first-page":"eabn7983","DOI":"10.1126\/sciadv.abn7983","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Semba T, Manyam GC et al (2022) EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Sci Adv 8(50):eabn7983. https:\/\/doi.org\/10.1126\/sciadv.abn7983","journal-title":"Sci Adv"},{"issue":"3","key":"11712_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.7150\/thno.81403","volume":"13","author":"RQ Li","year":"2023","unstructured":"Li RQ, Zhao XH, Zhu Q et al (2023) Exploring neurotransmitters and their receptors for breast cancer prevention and treatment. Theranostics 13(3):1109\u20131129. https:\/\/doi.org\/10.7150\/thno.81403","journal-title":"Theranostics"},{"issue":"10","key":"11712_CR40","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1007\/s11427-024-2809-y","volume":"68","author":"F Ji","year":"2025","unstructured":"Ji F, Chen X, Yang C et al (2025) Multi-omic-based classification for identifying optimal neoadjuvant treatment strategies for high-risk early-stage breast cancer. Sci China Life Sci 68(10):2934\u20132949. https:\/\/doi.org\/10.1007\/s11427-024-2809-y","journal-title":"Sci China Life Sci"},{"issue":"4","key":"11712_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s43018-024-00725-0","volume":"5","author":"YZ Jiang","year":"2024","unstructured":"Jiang YZ, Ma D, Jin X et al (2024) Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities. Nat cancer 5(4):673\u2013690. https:\/\/doi.org\/10.1038\/s43018-024-00725-0","journal-title":"Nat cancer"},{"key":"11712_CR42","doi-asserted-by":"publisher","first-page":"1701978","DOI":"10.3389\/fimmu.2026.1701978","volume":"17","author":"L Tang","year":"2026","unstructured":"Tang L (2026) Development and validation of an interpretable machine learning model identify the lactylation-related protein SUSD3 as a prognostic and therapeutic biomarker for breast cancer. Front Immunol 17:1701978. https:\/\/doi.org\/10.3389\/fimmu.2026.1701978","journal-title":"Front Immunol"},{"issue":"3","key":"11712_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/pcmedi\/pbab020","volume":"4","author":"Q Ma","year":"2021","unstructured":"Ma Q, Chen Y, Qin Q et al (2021) CXCL13 expression in mouse 4T1 breast cancer microenvironment elicits antitumor immune response by regulating immune cell infiltration. Precision Clin Med 4(3):155\u2013167. https:\/\/doi.org\/10.1093\/pcmedi\/pbab020","journal-title":"Precision Clin Med"},{"issue":"7","key":"11712_CR44","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/mc.23732","volume":"63","author":"X Wang","year":"2024","unstructured":"Wang X, Yang F, Sun Z et al (2024) NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis. Mol Carcinog 63(7):1392\u20131405. https:\/\/doi.org\/10.1002\/mc.23732","journal-title":"Mol Carcinog"},{"issue":"37","key":"11712_CR45","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/s41388-019-0893-4","volume":"38","author":"A Cordero","year":"2019","unstructured":"Cordero A, Kanojia D, Miska J et al (2019) FABP7 is a key metabolic regulator in HER2\u2009+\u2009breast cancer brain metastasis. Oncogene 38(37):6445\u20136460. https:\/\/doi.org\/10.1038\/s41388-019-0893-4","journal-title":"Oncogene"},{"key":"11712_CR46","doi-asserted-by":"publisher","unstructured":"Yang DD, Xue ZK, Jia SQ et al (2026) Bioinformatic analysis and cellular functional assays uncover the role of NXPH4 in breast cancer. Discover Oncol. https:\/\/doi.org\/10.1007\/s12672-026-04519-x","DOI":"10.1007\/s12672-026-04519-x"},{"issue":"2","key":"11712_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10719-020-09914-2","volume":"37","author":"JCF do Nascimento","year":"2020","unstructured":"do Nascimento JCF, Beltr\u00e3o EIC, Rocha CRC (2020) High FUT3 expression is a marker of lower overall survival of breast cancer patients. Glycoconj J 37(2):263\u2013275. https:\/\/doi.org\/10.1007\/s10719-020-09914-2","journal-title":"Glycoconj J"},{"issue":"1","key":"11712_CR48","doi-asserted-by":"publisher","first-page":"2447917","DOI":"10.1080\/07853890.2024.2447917","volume":"57","author":"G Huang","year":"2025","unstructured":"Huang G, Yu Y, Su H et al (2025) Integrating RNA-seq and scRNA-seq to explore the prognostic features and immune landscape of exosome-related genes in breast cancer metastasis. Ann Med 57(1):2447917. https:\/\/doi.org\/10.1080\/07853890.2024.2447917","journal-title":"Ann Med"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11712-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:51:12Z","timestamp":1787932272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11712-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":48,"alternative-id":["11712"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11712-1","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"16 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}